Despite beating Q2 estimates with 9% organic growth, Stryker's stock fell 9% as investors questioned cyber recovery and ...

The investment strengthens Atlantia’s US clinical operations as device manufacturers seek faster, more cost-effective ...

Each year, the medical device industry has highs and lows. And each year, MD+DI editors take the time to look at the companies and segments of the industry that have the biggest gains and the biggest ...

Independent laboratory data and engineering insights to support EM tracking technology and supplier evaluations.

Boston Scientific approved a restructuring plan that could reduce expenses by about $500 million a year and lead to the ...

Quasar Medical, a global contract development and manufacturing organization (CDMO) specializing in minimally invasive medical devices, announced the acquisition of the Medres' Nitinol Design and ...

Philips posts 4% Q2 sales growth but relies on EUR 186M tariff refund to boost margins by 4.2 points. Stock falls 9% on China ...

For life sciences executives evaluating digital health portfolios, anatomically informed architectures represent a defensible ...

Lindsey Dinneen tackles a critical truth: great ideas fail every day in medtech — not because they lack merit, but because ...

The surgical robotics company will wind down operations and liquidate assets after running out of cash to continue ...

Trump imposes 10-12.5% tariffs on 60 trade partners over forced labor claims, covering 99.4% of imports including medical ...

Regulatory expert Jessica Schafersman explains why device startups must integrate FDA compliance from concept phase, not ...